Show simple item record

dc.contributor.authorGoemaere, E
dc.contributor.authorFord, N
dc.contributor.authorBenatar, S R
dc.date.accessioned2008-05-26T15:11:53Z
dc.date.available2008-05-26T15:11:53Z
dc.date.issued2002-07-06
dc.identifier.citationHIV/AIDS prevention and treatment. 2002, 360 (9326):86-7; author reply 87-8 Lanceten
dc.identifier.issn0140-6736
dc.identifier.pmid12114064
dc.identifier.doi10.1016/S0140-6736(02)09343-1
dc.identifier.urihttp://hdl.handle.net/10144/28174
dc.language.isoenen
dc.publisherElsevieren
dc.rightsReproduced on this site with permission of Elsevier Ltd. Please see [url]http://www.thelancet.com/[/url] for further relevant comment.en
dc.subject.meshAcquired Immunodeficiency Syndromeen
dc.subject.meshAdulten
dc.subject.meshAfricaen
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshChilden
dc.subject.meshCost-Benefit Analysisen
dc.subject.meshDeveloping Countriesen
dc.subject.meshHumansen
dc.titleHIV/AIDS prevention and treatment.en
dc.identifier.journalLanceten
refterms.dateFOA2019-03-04T10:29:39Z


Files in this item

Thumbnail
Name:
Access Goemaere Lancet 2002.pdf
Size:
55.73Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record